Paul Shin Selected Research

Dextromethorphan (Racemethorphan)

12/2016	An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.
9/2016	Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
6/2016	PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
9/2015	Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Shin Research Topics

Disease

4	Dementia (Dementias) 12/2016 - 09/2015
3	Neoplasms (Cancer) 03/2022 - 06/2011
2	Multiple Sclerosis 12/2016 - 06/2016
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2016 - 06/2016
2	Stroke (Strokes) 09/2016 - 06/2016
2	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2016 - 06/2016
2	Diarrhea 09/2015 - 03/2012
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Cognitive Dysfunction 09/2015
1	Alzheimer Disease (Alzheimer's Disease) 09/2015
1	Urinary Tract Infections (Urinary Tract Infection) 09/2015
1	Pain (Aches) 05/2015
1	Migraine Disorders (Migraine) 05/2015
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2012

Drug/Important Bio-Agent (IBA)

4	Quinidine (Chinidin)FDA LinkGeneric 12/2016 - 09/2015
4	Dextromethorphan (Racemethorphan)FDA LinkGeneric 12/2016 - 09/2015
1	Indicators and Reagents (Reagents)IBA 03/2022
1	Floxuridine (FUdR)FDA LinkGeneric 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2021
1	PowdersIBA 05/2015
1	Tryptamines (Triptans)IBA 05/2015
1	Sumatriptan (Imigran)FDA LinkGeneric 05/2015
1	TabletsIBA 05/2015
1	alosetron (Lotronex)FDA Link 03/2012
1	aluminum sulfate (alum)IBA 06/2011

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
1	Therapeutics 01/2022